Dermatology
Vitiligo
Diagnosis, autoimmune screen, narrowband UVB, topical / oral therapies, JAK inhibitors emerging, psychological support.
Source: BAD 2008 (under review); European S1
Step 1 of ~2
info
Diagnose + Workup
Acquired depigmentation; autoimmune destruction of melanocytes. Wood's lamp examination accentuates patches.
Classification:
• Non-segmental (most common) — bilateral, symmetric, progressive.
• Segmental — unilateral, dermatomal, stable, often paediatric.
• Universal — >80% body surface.
Autoimmune associations: thyroid disease, T1DM, Addison's, alopecia areata, pernicious anaemia.
Workup: TFTs (most useful); FBC, glucose, B12, autoimmune screen if features.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Dapsone · Anti-inflammatory / Antimicrobial
- Nystatin 100,000 units/mL Oral Suspension · Antifungal — polyene (topical oral candidiasis treatment)
- Nystatin (Oral Suspension) · Antifungal (Polyene — Topical GI)
- Choline salicylate · Topical analgesic (oral mucosa)
- Clindamycin · Lincosamide Antibiotic
- Neomycin sulfate · Aminoglycoside antibiotic (topical/oral)
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD
Decision support only. Always apply local guidelines and clinical judgement.